120
Participants
Start Date
November 30, 2015
Primary Completion Date
September 30, 2017
Study Completion Date
November 30, 2017
JVS-100
Biological/Vaccine: JVS-100 Intramuscular Injection
Placebo
Biological/Vaccine: Placebo Intramuscular Injection
RECRUITING
St. Joseph's Hospital, Tampa
NOT_YET_RECRUITING
Cardiovascular Associates of the Southeast, Birmingham
RECRUITING
UC Davis, Davis
RECRUITING
Cedars-Sinai Heart Institute, Los Angeles
NOT_YET_RECRUITING
MedStar Georgetown UH, Washington D.C.
RECRUITING
Morton Plant Hosptial - Baycare, Clearwater
RECRUITING
Mount Sinai Medical Center, Miami
RECRUITING
Northwestern, Chicago
RECRUITING
RUMC, Chicago
RECRUITING
Cardiovascular Institute of the South, Houma
RECRUITING
St. John Hospital and Medical Center, Detroit
RECRUITING
Mayo, Rochester
RECRUITING
Cardiology Associates Research, Tupelo
RECRUITING
St. Luke's Mid America Heart Institute, Kansas City
RECRUITING
Holy Name Medical Center, Teaneck
RECRUITING
UNC, Chapel Hill
RECRUITING
NC Heart and Vascular Research, Raleigh
RECRUITING
Summa Health, Akron
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Metro Health, Cleveland
RECRUITING
University Hospitals, Cleveland
RECRUITING
Lifespan Health System, Providence
RECRUITING
VCU, Richmond
RECRUITING
Medical College of Wisconsin, Milwauke
Lead Sponsor
Juventas Therapeutics, Inc.
INDUSTRY